Type 1 diabetes (T1D) is an autoimmune condition associated with a high complication rate. Modern medicine enables patient control the disease; however, complications may still occur, kidney dysfunction, diabetic retinopathy, peripheral neuropathy, and vascular issues to name a few. Despite all the advances in modern medicine there is currently no way to prevent or reverse type 1 diabetes (T1D) with conventional treatments.
Stemwell stem cell therapy for diabetes directly supports the underlying issue, the inability to produce adequate insulin, leading to glucose dysregulation.
Type 1 diabetes (T1D), also known as insulin-dependent diabetes, is a chronic autoimmune condition in which the pancreas produces little to no insulin.
Type 1 diabetes develops because the body mistakenly identifies insulin-producing cells (beta cells) as being foreign and not belonging to self. The immune system targets and ultimately destroys the beta cells, resulting in little to no insulin production and the subsequent T1D diagnosis. This autoimmune process is thought to smolder for years, and there are individuals at risk of developing diabetes who do not yet have the diagnosis.
Research has shown, however, that by targeting the tiny blood vessels that oxygenate the pancreas, it is possible to regenerate tissue, promote new vessel growth, and thus sustain and restore insulin production and distribution.
In stem cell treatment for diabetes, mesenchymal stem cells derived from the umbilical cord can support the repair pancreatic tissue repair and insulin-producing cell regeneration.
In a healthy person, insulin, which is produced in the pancreas, aids in the absorption of glucose, allowing sugar to be converted into energy or stored for later use. The body relies on insulin to maintain healthy blood sugar levels.
Type 1 diabetes occurs when the body’s immune system destroys the pancreas’s insulin-producing beta cells (b-cells), leaving the body unable to produce insulin on its own.
Type 2 diabetes, the more common form, is distinguished by insulin resistance, a condition in which various tissues in the body no longer respond to the insulin that the pancreas produced. There is a subsequent progressive decline in b-cell function, to the point where the cells no longer produce enough additional insulin to overcome the insulin resistance.
Diabetes is a major problem because it usually leads to other diseases and complications. Regardless of whether your body does not produce insulin (type 1 diabetes) or is insulin resistant (type 2 diabetes), it is not properly regulating your blood-glucose levels. This can lead to long-term complications such as heart disease, stroke, diabetic neuropathy, and kidney failure.
Stem cells and regenerative cells in combination have been shown to repair cells, increase blood flow, and reduce inflammation. It has also been shown to be effective in supporting healthy immune responses and restoring the body to normal function.
Type 1 diabetes, also known as insulin-dependent diabetes, is a chronic disease in which the pancreas produces little to no insulin and the immune system destroys insulin-producing cells as well as the blood vessels that support them. Stemwell’s stem cells support the repair and regeneration of healthy insulin-producing cells and blood vessels.
Stemwell uses umbilical cord tissue-derived mesenchymal stem cells, ethically sourced from full-term human umbilical cords. We may administer 300 million cells that are all thoroughly tested for viability before treatment. These cells are NOT a blood product; therefore, stem cell therapy is safe and does not require HLA or phenotypic matching.
Video call with our patient advocates and our doctors where the patient’s condition and medical history will be discussed.
The patient undergoes an initial evaluation and blood work by Stemwell’s doctor.
Endovenous detox therapy applied to patient
Stem Cell IV Infusion Therapy + localized Autologous stem cell injections in trigger pain points under sedation
The fifth step is dedicated to addressing diabetes conditions through specialized therapies, including shockwave therapy, ultrasound, magnetotherapy, and laser therapy.
In certain cases, we may also utilize photobiomodulation to address diabetes symptoms or explore its potential benefits.
Because human umbilical cord mesenchymal stem cells (HUC-MSCs) are immune system privileged, cell rejection is not an issue, and human leukocyte antigen (HLA) matching is not required. We screen and select stem cells with the best anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration. Allogeneic stem cells can be administered in uniform doses with high cell counts multiple times over the course of several days.
Umbilical cord tissue provides an abundant supply of MSCs. There is no need to collect stem cells from the patient’s hip bone or fat under anesthesia, which can be a traumatic experience for small children and their parents. A growing body of evidence suggests that MSCs derived from umbilical cord tissue are more robust than MSCs derived from other sources.
There is no need to administer chemotherapy drugs such as Granulocyte-colony stimulating factor (G-CSF or GCSF) to stimulate bone marrow granulocyte and stem cell production and their release into the bloodstream.
Stemwell’s adult stem cells are derived from human umbilical cord tissue and are used to treat autoimmune diseases (allogeneic mesenchymal). These stem cells are expanded in our cutting-edge laboratory.
The umbilical cord mesenchymal stem cells (MSCs) we use are recovered from young, healthy donors following normal, healthy births. Each potential donor is vetted and tested for infectious diseases. Prior to donation, each family provides written consent.
Before being approved for use in patients, all umbilical cord-derived stem cells are tested for infectious diseases in accordance with International Blood Bank Standards.
Only a small percentage of donated umbilical cords make it through our stringent screening process.
Our mission is to bring hope, healing, and a personalized plan to every patient we meet. We believe the caring hands and expertise of our doctors along with our proven protocols provide the best possible outcomes. We follow the highest ethical international standards offering transparency, honesty, and clinical accuracy.
Email
[email protected]
Address
Cra. 13 #118-08, Bogotá, Colombia
Telephone
+57 314 8079475
+57 601 3789412
Stem cell therapy offers no guarantees and is not promoted as a cure. This is similar to many other medical treatments. Reviewing the patient’s medical history is necessary to determine stem cell therapy eligibility. Any personal information provided is for internal and medical use with our medical providers only. The Stemwell Health headquarters is located in McLean, Virginia. Stemwell Health Virginia is not a stem cell treatment facility or surgical center. Treatments are not conducted anywhere in the US, since these advanced therapies are not yet FDA-approved. All cell therapies are conducted in Colombia where it is regulated by the ministry of health, INVIMA (Columbia’s FDA equivalent) and other local authorities. All treatments are performed within the country’s legal limits and regulatory framework where the specific medical provider practices.
